https://www.sciencedaily.com/releases/2018/08/180816153147.htm

"By editing a single base in genomic DNA using CRISPR-SKIP, we can eliminate exons permanently and, therefore, achieve a long-lasting correction of the disease with a single treatment," said Alan Luu, a physics graduate student and co-first author of the study. "The process is also reversible if we would need to turn an exon back on." Also demonstrated that differently targeted CRISPR-SKIPs can be combined to skip multiple exons in one gene if necessary.

Views: 86

Reply to This

Need help using this community site? Visit Ning's Help Page.

Members

Events

© 2018   Created by PPMD.   Powered by

Badges  |  Report an Issue  |  Privacy Policy  |  Terms of Service